-
"Forest Laboratories and Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythmic Agent"
Business Wire, April 2011
-
"For these prodigal entrepreneurs, Ohio is home sweet home"
Hi Velocity, July 2010
-
"Heart Drug marketer wins funding"
Cincinnati Enquirer, April 2010
-
"Blue Ash Therapeutics raises $2M-plus to push drug over finish line"
Med City News, April 2010
-
"Former P&Gers develop new drug for Blue Ash Therapeutics, gain $2 million in startup funds"
Soapbox Cincinnati, April 2010
-
"Blue Ash Therapeutics wins CincyTech venture funding"
Business Courier, April 2010
-
"Blue Ash Therapeutics receives investment"
CincyTech, April 2010
|
